Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer

    NEXT STORY
    Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    PREV STORY
    Aptose to Present at the Jefferies 2019 Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chembio to Sell Its SURE CHECK® HIV 1/2 Assay in the United States Beginning June 1, 2016

    MEDFORD, N.Y., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

    author_avatar
    NASDAQ Market News

    BeiGene to Hold Conference Call and Webcast on September 8, 2019 at 7:00 p.m. ET to Provide Corporate Update

    author_avatar
    NASDAQ Market News

    CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health & Medicine Annual Conference in San Diego, CA – October 22-25, 2017

    LAS VEGAS, Oct. 10, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," ...

    author_avatar
    NASDAQ Market News